Announcement under Regulation 30 (LODR)-Press Release / Media Release 6 Oct - GCPL inaugurates first phase of Kendal, Indonesia plant; IDR 500 billion investment expands capacity 15%.
Source: Bse
FMCG stocks · Large cap · NSE
Godrej Consumer Products Limited (GCPL) is an Indian consumer goods company focused on health and beauty products in emerging markets. Its strategy involves category development, portfolio transformation, and an operating philosophy of 'Less is more; Much less is much more'.
full bear SMA stack · SMA20 -3.2% / mo · MACD + · near 52W low · sector -4.5pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is consistent.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +15.4% · PAT +11.7% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
margin compression · Rev +15% YoY · PAT +12% YoY · +8% QoQ
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹4,225 Cr | +15.4% | +8.3% |
| EBITDA | ₹801 Cr | +15.3% | -4.8% |
| Operating margin | 19.0% | +0 bps | -300 bps |
| PAT | ₹505 Cr | +11.7% | +11.7% |
| PAT margin | 11.9% | -39 bps | +36 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 19/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is weak — long-term trend down. RSI 39.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 36 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Consumer franchises can deserve higher multiples, but only when growth quality supports them.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in FMCG — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q4 FY2026 sees consolidated revenue up 11% and EBITDA up 10%, driven by strong standalone performance. Standalone UVG was 7%, with Home Care leading growth. International segments showed mixed results, with Indonesia facing pricing pressure and Latin America impacted by one-time costs.
While standalone business delivered solid growth and margin expansion, international segments, particularly Indonesia and Latin America, show signs of stress. The accounting change for customer-related spends impacts revenue presentation, requiring careful re-evaluation of historical growth trends.
Latest issuer-disclosed distribution across 4 reported categories.
Delivered double-digit sales growth (12% YoY) led by Household Insecticides, Air Fresheners, and Fabric Care.
Electrics delivered strong growth and gained market share; Incense sticks scaled up strongly.
Continued strong double-digit growth momentum across formats, gaining market share and leadership.
Continued strong performance across key markets.
Scaled up to pan-India post robust results in Tamil Nadu, targeting a ~3K crore category.
Delivered strong performance and scaled up pan-India.
Soaps continue positive trajectory led by improving affordability post GST reduction.
Pricing pressure largely bottomed out; early signs of stabilisation.
EBITDA growth impacted by one-time costs.
Sales growth includes impact of change in distribution arrangement (-2%).
New EAC opinion from ICAI requires reclassification of certain customer-related spends as reduction from revenue, impacting reported sales.
Indonesia expects operating conditions to improve from FY27, indicating current challenges.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The investor presentation primarily reports financial performance and growth metrics on a year-on-year basis, which is standard for assessing performance in a consumer goods business with potential seasonality.
6% YoY
7% YoY
11% YoY
10% YoY
Expect operating conditions to improve from FY27.
Committed to internal Scope 1 and 2 Net-zero by 2035, aligned with SBTi.
Completed community waste management projects in 5 municipalities in FY26, diverting 23,390 MT waste.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Indonesia Operating Conditions | Early signs of stabilisation, pricing pressure largely bottomed out. | Sustained improvement in operating conditions and sales growth from FY27. |
| Standalone Personal Care Growth | 3% YoY sales growth, with focus on upgrading consumers to handwash, bodywash, facewash. | Acceleration in Personal Care growth, especially premium formats, to match Home Care momentum. |
| Impact of Accounting Change | Reclassification impacts revenue from operations and certain ratios, but not EBITDA or PAT. | Clarity on the full impact of the accounting change on reported revenue trends and investor perception. |
| Africa, USA & Middle East Profitability | Strong topline growth (20%) but EBITDA growth only 2% due to doubling media spends. | Improved EBITDA growth as media spends normalize or drive higher leverage. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 72nd percentile of the scored universe and 30th percentile within FMCG. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · FMCG: 30th pctile, median 79 · Large: 51st pctile, median 73
97 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse